News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,320 Results
Type
Article (41579)
Company Profile (259)
Press Release (665482)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (206350)
Career Advice (2037)
Deals (35730)
Drug Delivery (95)
Drug Development (81434)
Employer Resources (172)
FDA (16314)
Job Trends (15054)
News (348596)
Policy (33002)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2637)
Academic (1)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (50238)
ALS (88)
Alzheimer's disease (1391)
Antibody-drug conjugate (ADC) (124)
Approvals (16318)
Artificial intelligence (254)
Autoimmune disease (21)
Automation (16)
Bankruptcy (364)
Best Places to Work (11709)
BIOSECURE Act (20)
Biosimilars (105)
Biotechnology (180)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (278)
Cancer (2258)
Cardiovascular disease (177)
Career advice (1705)
Career pathing (31)
CAR-T (150)
Cell therapy (422)
Cervical cancer (20)
Clinical research (66180)
Collaboration (839)
Compensation (524)
Complete response letters (19)
COVID-19 (2638)
CRISPR (41)
C-suite (242)
Cystic fibrosis (100)
Data (2199)
Decentralized trials (2)
Denatured (18)
Depression (42)
Diabetes (271)
Diagnostics (6539)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (87042)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (113189)
Executive appointments (726)
FDA (17563)
Featured Employer (48)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (756)
Gene editing (106)
Generative AI (19)
Gene therapy (303)
GLP-1 (720)
Government (4463)
Grass and pollen (4)
Guidances (59)
Healthcare (18953)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (29)
Infectious disease (2783)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (315)
IPO (16579)
IRA (40)
Job creations (3754)
Job search strategy (1449)
Kidney cancer (10)
Labor market (38)
Layoffs (471)
Leadership (18)
Legal (8027)
Liver cancer (75)
Lung cancer (323)
Lymphoma (153)
Machine learning (7)
Management (58)
Manufacturing (304)
MASH (67)
Medical device (13441)
Medtech (13446)
Mergers & acquisitions (19695)
Metabolic disorders (687)
Multiple sclerosis (80)
NASH (17)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1924)
NextGen: Class of 2025 (6552)
Non-profit (4538)
Northern California (2669)
Now hiring (39)
Obesity (365)
Opinion (207)
Ovarian cancer (75)
Pain (85)
Pancreatic cancer (83)
Parkinson's disease (149)
Partnered (21)
Patents (233)
Patient recruitment (110)
Peanut (47)
People (57930)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20629)
Phase II (29119)
Phase III (21708)
Pipeline (1189)
Policy (140)
Postmarket research (2589)
Preclinical (8856)
Press Release (67)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (380)
Real estate (6121)
Recruiting (65)
Regulatory (22585)
Reports (46)
Research institute (2382)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (131)
Series B (84)
Service/supplier (11)
Sickle cell disease (53)
Southern California (2299)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3621)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (39)
The Weekly (31)
United States (23115)
Vaccines (689)
Venture capitalists (41)
Weight loss (237)
Women's health (35)
Worklife (16)
Date
Today (163)
Last 7 days (851)
Last 30 days (2632)
Last 365 days (33017)
2025 (10629)
2024 (35424)
2023 (40336)
2022 (51426)
2021 (56015)
2020 (54495)
2019 (46961)
2018 (35330)
2017 (32509)
2016 (31983)
2015 (38005)
2014 (31860)
2013 (26980)
2012 (29103)
2011 (29781)
2010 (27820)
Location
Africa (734)
Alabama (53)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38648)
Australia (6325)
California (6120)
Canada (2018)
China (524)
Colorado (267)
Connecticut (272)
Delaware (146)
Europe (83266)
Florida (907)
Georgia (206)
Idaho (57)
Illinois (534)
India (25)
Indiana (307)
Iowa (11)
Japan (161)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (892)
Massachusetts (4562)
Michigan (219)
Minnesota (393)
Mississippi (2)
Missouri (87)
Montana (30)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1727)
New Mexico (29)
New York (1742)
North Carolina (982)
North Dakota (8)
Northern California (2669)
Ohio (207)
Oklahoma (14)
Oregon (34)
Pennsylvania (1373)
Puerto Rico (12)
Rhode Island (33)
South America (1126)
South Carolina (22)
South Dakota (1)
Southern California (2299)
Tennessee (101)
Texas (909)
Utah (182)
Virginia (144)
Washington D.C. (61)
Washington State (552)
West Virginia (3)
Wisconsin (54)
707,320 Results for "mesa laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025
January 17, 2025
·
1 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
Mesa Laboratories, Inc. will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 as previously communicated.
May 31, 2024
·
1 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
Mesa Laboratories, Inc. will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 31, 2024.
May 22, 2024
·
1 min read
Business
Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024
Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 24, 2024.
April 1, 2024
·
1 min read
Business
Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024
Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on Monday, February 5, 2024.
December 14, 2023
·
1 min read
Business
Mesa Laboratories Appoints Mark Capone to its Board of Directors
Mesa Laboratories, Inc., a global leader in the design and manufacturing of life science tools and critical quality control solutions, announced the appointment of Mark Capone to its Board of Directors, effective January 5, 2024.
January 8, 2024
·
2 min read
Business
Mesa Labs Declares Quarterly Dividend - April 04, 2024
Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.
April 4, 2024
·
2 min read
Press Releases
Mesa Labs Announces Third Quarter Results
February 4, 2025
·
18 min read
BioMidwest
Mesa Labs Releases Second Annual Responsible Business Program Brochure
Mesa Laboratories, Inc. announced the release of its second annual Environmental, Social and Governance Program Brochure.
March 15, 2024
·
4 min read
Business
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results
Mesa Laboratories, Inc., a global leader in the design and manufacture of life science tools and critical quality control solutions, announced results for its fourth fiscal quarter and fiscal year ended March 31, 2024.
June 5, 2024
·
22 min read
1 of 70,732
Next
